NKMAX_AMERICA-300x215.png
NKMax America To Present Data from its Natural Killer Cell Immunotherapy Clinical Program at the ASCO20 Virtual Scientific Program
April 30, 2020 08:00 ET | NKMax America
SANTA ANA, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
NKMAX_AMERICA-300x215.png
NKMax America Announces Acceptance of Three Abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting
March 31, 2020 07:30 ET | NKMax America
SANTA ANA, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
NKMAX_AMERICA-300x215.png
NKMax America to Present at the Upcoming NIH-AACR Cancer, Autoimmunity, and Immunology Conference
March 17, 2020 20:00 ET | NKMax America
SANTA ANA, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
NKMAX_AMERICA-300x215.png
NKMax America to Present at Immuno-Oncology Summit Europe 2020
March 09, 2020 16:01 ET | NKMax America
SANTA ANA, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...
NKMAX_AMERICA-300x215.png
NKMax America to Present Corporate Overview at the Cowen & Company 40th Annual Health Care Conference
March 03, 2020 07:00 ET | NKMax America
SANTA ANA, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...